Delivery Order SPE2DB22D1106-SPE2DB25FEND8

Award Date 5/13/25
Potential Completion Date 5/14/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $9,076.45 and covers the delivery of DEXMEDETOMIDINE 200 MCG/2 ML 2ML, a medical product used in healthcare settings. The contract is a firm fixed-price delivery order, with a period of performance through February 11, 2025. AmerisourceBergen holds a larger Indefinite...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4,564,203,919 units of the pharmaceutical product Dexmedetomidine 200 mcg/2 ml 2 ml. The order has a ceiling value of $4,104.39 and a period of performance through April 9, 2024. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
The federal contract award is for the delivery of 4563422255 DEXMEDETOMIDINE 200 MCG/2 ML 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,637.87 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and...
This is a firm fixed price delivery order (SPE2DB20D3103|SPE2DB24FN1G3) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $7,005.08 contract is for the delivery of 4564029850 - DEXMEDETOMIDINE 200 MCG/2 ML 2ML, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded solely to Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Dexmedetomidine 200 mcg/2 ml injection. The contract has a ceiling value of $9,615.22 and an ultimate completion date of December 7, 2023. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $1,203.90. The contract is for medical supplies, including 4558644428 - SOL IV VFLX 10% DEX PLS CNTNR 250ML LF. It has a firm fixed price with a completion date of September 30, 2022. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The order, valued at $1,260.60, is for the supply of 4564166058 DEXMETHYLPHN 20MG 100S, a pharmaceutical product, in support of military treatment programs and facilities. This delivery order falls under a larger indefinite delivery contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DEXMETHYLPHENIDATE ER 5 MG CAP 100S. The contract has a firm fixed price of $2,164.24 and a completion date of October 8, 2024. It is not a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,132.76 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of 4563480335 ! DEXMETHYLPHENIDATE ER 30 MG CP 100S, a pharmaceutical product, to support military treatment programs and facilities. This order is part of a larger indefinite delivery contract (IDC) with a potential value of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,508.13 and a performance period through May 2025. It is a firm fixed-price contract for the delivery of various pharmaceutical and medical products, including medications across multiple therapeutic areas such as diabetes, neurology, pain management, and antibiotics. The...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEND8
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568233987 - Dexmedetomidine 200 mcg/2 ml 2 ml, a medication used for sedation. The contract has a firm fixed price of $1,244.00 and a completion date of May 14, 2025.

AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The contract award discussed is not set aside, indicating open competition.

Generated 8/12/25, 12:03 PM